CDC advisory committee to vote on Pfizer vaccine for children ages 5-11
ABC News
The Pfizer vaccine for kids 5-11 could be available as soon as Wednesday after a CDC advisory panel vote, although the program is expected to ramp up over the next week.
A committee of independent experts advising the Centers for Disease Control and Prevention is set to vote Tuesday whether to recommend the Pfizer vaccine for children 5-11, checking off one of the last boxes in the authorization process.
If members of the committee vote to recommend use of the vaccine, CDC Director Rochelle Walensky is expected to then issue a recommendation as soon as Tuesday evening, the final step in the process, which would allow the first shots to be administered as soon as Wednesday morning.
But vaccinations are not expected to kick into high-gear until Nov. 8, when the White House says Pfizer’s pediatric vaccines will be more widely accessible across the nation.
About 15 million doses are expected to ship out over the next week. The majority, about 10 million, will be available at pediatrician's offices, children’s hospitals, community centers and mass vaccination sites. About 5 million doses will go to pharmacies.
